Minimally Invasive Transperineal Laser Ablation of the Prostate Appears Effective
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 3, 2023 -- Minimally invasive transperineal laser ablation (TPLA) of the prostate appears effective for benign prostatic hyperplasia (BPH), according to a review published online Sept. 21 in Therapeutic Advances in Urology.
Lazaros Tzelves, from the University College London Hospitals, and colleagues conducted a systematic literature review to examine the safety and efficacy of TPLA for BPH.
Based on 11 included studies, the researchers found that functional outcomes were improved in the majority of studies both for objective (maximum flow rate and postvoid residual) and subjective outcomes (improvement of International Prostate Symptom Score and quality of life). Complications included hematuria (range: 1.9 to 2.3 percent), dysuria (3.7 to 36.3 percent), acute urinary retention (1.9 to 19 percent), orchitis/urinary tract infections (0.6 to 9.1 percent), and prostatic abscess formation (0.6 to 4.8 percent). The vast majority of patients (>95 percent) retained their ejaculation, while erectile function was maintained or improved.
"TPLA of the prostate is an innovative, minimally invasive technique for managing patients with BPH," the authors write. "Existing studies indicate an effective technique in reducing International Prostate Symptom Score and quality of life scores, postvoid residual reduction, and increase in Qmax [maximum urinary flow rate], albeit the measured improvements in terms of Qmax are not equal to transurethral resection of the prostate."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Mortality in Rheumatic Heart Disease Is High
FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...
Higher County-Level Prostate Cancer Screening Tied to Better Outcomes
FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...
Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer
FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.